Select Page

A valuable overview of the most important clinical trials for UK neuroendocrine cancer patients was made by Kate Quirk from Neuroendocrine Cancer UK.  The article on NCUK website includes basic educational background for patients on clinical trials and also highlights of the ‘Trials That Matter’ presented by experts. Kate spoke to members of NCUK Clinical Advisory panel to gain their views on which are the ‘Trials That Matter’ this year and what their opinions are on likely outcomes based on what they’re seeing in UK Centres of Excellence.

Kate Quirk, Neuroendocrine Cancer UK
Kate Quirk is a Patient Advocate with Neuroendocrine Cancer UK and INCA Research Advocate, intensely involved in INCA’s Research Committee activity.


Read the NCUK article